Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Aricept now available in Canada

Sep. 8, 1997

Cambridge NeuroScience moves CNS-5161 to clinical trials

Sep. 8, 1997

RTP licenses improved propofol formulation to AMRAD

Sep. 5, 1997

SK-946: a potent and selective muscarinic M1 receptor agonist from Sanwa Kagaku

Sep. 5, 1997

New 5-HT3 receptor ligand with agonist activity in the gut

Sep. 5, 1997

AWD-140-190: new anticonvulsant with favorable efficacy and safety profile

Sep. 5, 1997

Warner-Lambert/CoCensys disclose subtype-selective NMDA antagonists

Sep. 5, 1997

Nicotinic agonist protects against neuronal cell death in rodents

Sep. 5, 1997

Novartis migraine treatment nears U.S. approval

Sep. 5, 1997

Beneficial effects of TDN-345 in animal models of cerebrovascular disease

Sep. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...